381 related articles for article (PubMed ID: 18258334)
1. Multiple skin metastases of malignant melanoma with unusual clinical and histopathologic features in an immunosuppressed patient.
Egberts F; Kaehler KC; Brasch J; Schwarz T; Cerroni L; Hauschild A
J Am Acad Dermatol; 2008 May; 58(5):880-4. PubMed ID: 18258334
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
3. Melanocytic nevi clinically simulating melanoma.
Makino E; Uchida T; Matsushita Y; Inaoki M; Fujimoto W
J Dermatol; 2007 Jan; 34(1):52-5. PubMed ID: 17204102
[TBL] [Abstract][Full Text] [Related]
4. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
Urso C
J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
[TBL] [Abstract][Full Text] [Related]
5. Plantar melanoma that mimics melanocytic nevi: a report of 4 cases with lymph node metastases and with review of positive and negative controls.
Massi G; Vellone VG; Pagliarello C; Fabrizi G
Am J Dermatopathol; 2009 Apr; 31(2):117-31. PubMed ID: 19318796
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
7. Large atypical melanocytic nevi in recessive dystrophic epidermolysis bullosa: clinicopathological, ultrastructural, and dermoscopic study.
Gallardo F; Toll A; Malvehy J; Mascaró-Galy JM; Lloreta J; Barranco C; Pujol RM
Pediatr Dermatol; 2005; 22(4):338-43. PubMed ID: 16060872
[TBL] [Abstract][Full Text] [Related]
8. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
10. Pagetoid melanocytosis: tease or tocsin?
Stern JB; Haupt HM
Semin Diagn Pathol; 1998 Aug; 15(3):225-9. PubMed ID: 9711673
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
12. Metastatic malignant melanoma presenting as pancytopenia in a three-year-old boy.
Spiller SE; Hawkins DS; Finn LS; Sze RW; Sybert V
Pediatr Blood Cancer; 2005 Jul; 45(1):60-3. PubMed ID: 15800910
[TBL] [Abstract][Full Text] [Related]
13. Fatal malignant melanoma in a child with neurofibromatosis type 1.
Bin Amer Y; Al-Khenaizan S
Int J Dermatol; 2007 Sep; 46(9):967-70. PubMed ID: 17822504
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
16. In vivo confocal microscopic and histopathologic correlations of dermoscopic features in 202 melanocytic lesions.
Pellacani G; Longo C; Malvehy J; Puig S; Carrera C; Segura S; Bassoli S; Seidenari S
Arch Dermatol; 2008 Dec; 144(12):1597-608. PubMed ID: 19075142
[TBL] [Abstract][Full Text] [Related]
17. Epidermolysis bullosa nevus: an exception to the clinical and dermoscopic criteria for melanoma.
Cash SH; Dever TT; Hyde P; Lee JB
Arch Dermatol; 2007 Sep; 143(9):1164-7. PubMed ID: 17875878
[TBL] [Abstract][Full Text] [Related]
18. Regressing malignant melanoma.
Grafton WD
J La State Med Soc; 1994 Dec; 146(12):535-9. PubMed ID: 7844465
[TBL] [Abstract][Full Text] [Related]
19. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
20. Large melanocytic nevi in hereditary epidermolysis bullosa.
Bauer JW; Schaeppi H; Kaserer C; Hantich B; Hintner H
J Am Acad Dermatol; 2001 Apr; 44(4):577-84. PubMed ID: 11260529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
